Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",Inverse variance weighted,27,1.01 [0.95-1.08],0.700364894450334
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Early onset COPD,Inverse variance weighted,27,1.02 [0.96-1.09],0.512842031370881
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Later onset COPD,Inverse variance weighted,27,1.03 [0.98-1.09],0.220991162440206
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",Inverse variance weighted,27,0.99 [0.94-1.04],0.686682360088005
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,Inverse variance weighted,27,1.03 [1.00-1.07],0.0892158613717516
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",Inverse variance weighted,27,1.01 [0.97-1.05],0.573224104668562
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,Inverse variance weighted,27,0.99 [0.97-1.02],0.596549173079382
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,Inverse variance weighted,27,1.00 [0.98-1.03],0.942735547155603
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",Inverse variance weighted,27,1.01 [0.98-1.04],0.676856589031951
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Hypotension,Inverse variance weighted,27,0.95 [0.89-1.02],0.138065621101617
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",Inverse variance weighted,27,1.00 [0.75-1.35],0.981658296249971
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",Inverse variance weighted,27,1.00 [0.98-1.02],0.916161056240893
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",Inverse variance weighted,27,1.01 [0.98-1.04],0.591337643985805
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,Inverse variance weighted,27,1.03 [0.93-1.15],0.55137715629941
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,Inverse variance weighted,27,0.92 [0.84-1.02],0.108676594039764
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,Inverse variance weighted,27,1.03 [0.90-1.18],0.657438882573208
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Interstitial lung disease,Inverse variance weighted,27,1.00 [0.92-1.09],0.93364914884403
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,Inverse variance weighted,27,0.96 [0.87-1.06],0.434835004980767
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,Inverse variance weighted,27,0.97 [0.91-1.04],0.377083048700853
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Bronchiectasis,Inverse variance weighted,27,0.95 [0.87-1.04],0.28286355924999
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Emphysema,Inverse variance weighted,27,1.00 [0.89-1.12],0.978280842797084
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,Inverse variance weighted,27,1.00 [0.98-1.02],0.770044489826594
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,Inverse variance weighted,27,1.03 [1.01-1.05],0.0140338815797894
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,Inverse variance weighted,27,1.00 [0.97-1.03],0.957395765353107
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other diseases of pleura,Inverse variance weighted,27,1.02 [0.99-1.06],0.23314491637838
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Any mental disorder,Inverse variance weighted,27,1.01 [0.99-1.03],0.315944566510193
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",Inverse variance weighted,27,0.99 [0.95-1.04],0.760106857145685
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,27,1.00 [0.94-1.06],0.993390831694239
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,27,0.99 [0.94-1.03],0.612753495920548
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,27,1.01 [0.98-1.03],0.638599198540416
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Smoking dependency,Inverse variance weighted,27,0.93 [0.85-1.02],0.142634207735395
